Pharma14 has recently added ex-factory prices for the Japanese medicine market.
Current price data will now include ex-factory, wholesale and retail prices on more than 10,000 medicines including all administration routes and dosage forms.
As the rest of the Pharma14 platform, all Japanese data is updated monthly and includes full MA holder information and reimbursement status.
Sample data: Adalimumab / Humira Ex-factory, wholesale and retail prices.